Temozolomide Hexyl Ester
替莫唑胺酯
Report date: 2022/03/23 11:16:18
NME
Base Information
Drug NameTemozolomide Hexyl Ester
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (IND)
Highest Status in ChinaPending
Originator CompaniesTianjin Tasly Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesN/A
Inactive CompaniesTasly Holding Group Company Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A